TANG CAPITAL MANAGEMENT LLC Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$712.2B
Holdings
25
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ODONATE THERAPEUTICS INC | 14,075,269 | $388.6B | 54.57% | |
| 2 | RLMDRELMADA THERAPEUTICS INC | 1,300,000 | $44.3B | 6.23% | |
| 3 | RCKTROCKET PHARMACEUTICALS INC | 2,965,485 | $41.4B | 5.81% | |
| 4 | HRTXHERON THERAPEUTICS INC | 2,896,904 | $34.0B | 4.78% | |
| 5 | —LA JOLLA PHARMACEUTICAL CO | 8,080,345 | $33.9B | 4.77% | |
| 6 | ANABANAPTYSBIO INC | 2,290,827 | $32.4B | 4.55% | |
| 7 | BUWABIO RAD LABS INC | 80,000 | $28.0B | 3.94% | |
| 8 | UTHUNITED THERAPEUTICS CORP DEL | 208,415 | $19.8B | 2.78% | |
| 9 | —AVROBIO INC | 1,000,000 | $15.6B | 2.18% | |
| 10 | EOLSEVOLUS INC | 3,295,000 | $13.7B | 1.92% | |
| 11 | GBYSANGAMO THERAPEUTICS INC | 2,032,980 | $12.9B | 1.82% | |
| 12 | EGRXEAGLE PHARMACEUTICALS INC | 255,616 | $11.8B | 1.65% | |
| 13 | PBYIPUMA BIOTECHNOLOGY INC | 800,000 | $6.8B | 0.95% | |
| 14 | CHRSCOHERUS BIOSCIENCES INC | 350,000 | $5.7B | 0.80% | |
| 15 | —LIFESCI ACQUISITION CORP | 500,000 | $5.0B | 0.70% | |
| 16 | PRTAPROTHENA CORP PLC | 423,823 | $4.5B | 0.64% | |
| 17 | —RADIUS HEALTH INC | 300,000 | $3.9B | 0.55% | |
| 18 | VNDAVANDA PHARMACEUTICALS INC | 299,800 | $3.1B | 0.44% | |
| 19 | CTMXCYTOMX THERAPEUTICS INC | 300,000 | $2.3B | 0.32% | |
| 20 | GTHXEURG1 THERAPEUTICS INC | 170,000 | $1.9B | 0.26% | |
| 21 | ENTAENANTA PHARMACEUTICALS INC | 13,483 | $693.0M | 0.10% | |
| 22 | ITCIEURINTRA CELLULAR THERAPIES INC | 41,444 | $637.0M | 0.09% | |
| 23 | CMRXEURCHIMERIX INC | 431,273 | $621.0M | 0.09% | |
| 24 | —NUCANA PLC | 100,000 | $583.0M | 0.08% | |
| 25 | UPSUNITED PARCEL SERVICE INC | 1,000 | $93.0M | 0.01% |